Osteomyelitis

Preview

Infection of bone remains difficult to treat, despite recent advances in antimicrobial therapy and refinements in surgical technique. To add to the challenge, studies have been inconclusive in establishing the best method of obtaining a culture specimen, comparing the effectiveness of one drug regimen versus another, and determining the proper duration of antibiotic therapy. Dr Bamberger summarizes his experience with hematogenous osteomyelitis and osteomyelitis secondary to a contiguous focus of infection.

Additional information

Notes on contributors

David M. Bamberger

David M. Bamberger, MD Dr Bamberger is associate professor of medicine, section of infectious diseases, University of Missouri—Kansas City School of Medicine.